Validate the core BIOS modules
Initial features operate in a closed environment.
- Health Memory and data provenance
- BIOS Intelligence and AI hypotheses
- data protection and legal documents
- initial clinical pilots
Strategy 2030
The BIOS strategy to 2030.
Validate our proprietary algorithm, launch repeatable clinical use cases and develop products for patients, clinics and research projects.
Each stage begins only after the previous one has been validated.
26
Validate the foundation
NowHealth Memory, security and initial pilots.
27
Make implementation repeatable
A consistent process and ready-to-use integrations.
28
Connect partners
Clinics, laboratories and joint programmes.
30
Enter new countries
Adapt to local laws, languages and clinical workflows.
Roadmap
Five stages to 2030
Status as of July 2026.
Reproduce pilot results
Turn a pilot into a clearly defined implementation process.
- a consistent launch plan
- ready-to-use source integrations
- performance measures
- AI version control
Connect clinics and laboratories
BIOS Personal and BIOS Clinical work together.
- BIOS clinic network
- laboratory integration
- partner programmes
- monitoring after appointments
Launch research programmes
Study changes over time while preserving individual control.
- approved protocols
- coded datasets
- observational studies
- public system reports
Work across healthcare systems
Account for local laws, languages and clinical processes.
- regional data rules
- international exchange standards
- separation of organisations and access rights
- BIOS products on a shared foundation
What needs to grow
Scale starts with a validated system
We do not expand access before the technology, clinical processes and data protection are ready.
The history continues between visits
Data, verification and monitoring.
Results can be reproduced and verified
Protocols, benchmarks and quality monitoring.
Clinics, laboratories, pharma and researchers work together
Each participant has a clear role.
Security is independently assessed
Not just internal oversight.
The product accounts for each country’s rules
Law, language and clinical workflows.
Pilots become a repeatable product
Without selling personal medical data.
Conditions for scaling
Each stage must be earned
Evidence, not the calendar, determines progress.
Safety
Boundaries are defined
Failure scenarios are tested
An owner and rollback plan are in place
Value
Measures are agreed in advance
The team has adopted the process
Results are reproducible
Trust
Lawful basis
Security assessment
Clear communication
System operations
Quality monitoring
Incident response
Support and accountability
Scale starts with a strong foundation.
We seek partners for validation, integration and growth.